Extremely low frequency magnetic field induces human neuronal differentiation through NMDA receptor activation.
Extremely low frequency magnetic field (ELF MF)
Human neural progenitor cells (hNPCs)
N-methyl-D-aspartate (NMDA) receptor
Neuronal differentiation
Journal
Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
05
05
2019
accepted:
09
07
2019
pubmed:
19
7
2019
medline:
25
8
2020
entrez:
19
7
2019
Statut:
ppublish
Résumé
Magnetic fields with different frequency and intensity parameters exhibit a wide range of effects on different biological models. Extremely low frequency magnetic field (ELF MF) exposure is known to augment or even initiate neuronal differentiation in several in vitro and in vivo models. This effect holds potential for clinical translation into treatment of neurodegenerative conditions such as autism, Parkinson's disease and dementia by promoting neurogenesis, non-invasively. However, the lack of information on underlying mechanisms hinders further investigation into this phenomenon. Here, we examine involvement of glutamatergic Ca
Identifiants
pubmed: 31317262
doi: 10.1007/s00702-019-02045-5
pii: 10.1007/s00702-019-02045-5
doi:
Substances chimiques
Excitatory Amino Acid Antagonists
0
Receptors, N-Methyl-D-Aspartate
0
Memantine
W8O17SJF3T
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1281-1290Références
J Neurosurg. 2002 Mar;96(3):589-96
pubmed: 11883846
Biochem Biophys Res Commun. 2002 Aug 30;296(4):1013-8
pubmed: 12200150
J Neurosci. 1992 Aug;12(8):2973-81
pubmed: 1322980
FASEB J. 1992 Oct;6(13):3177-85
pubmed: 1397839
Cytometry A. 2004 Apr;58(2):167-76
pubmed: 15057970
FASEB J. 2005 Oct;19(12):1686-8
pubmed: 16116041
Curr Opin Pharmacol. 2006 Feb;6(1):61-7
pubmed: 16368266
Bioelectromagnetics. 2006 Dec;27(8):641-51
pubmed: 16838272
Neurosci Lett. 2007 Feb 14;413(2):145-9
pubmed: 17196332
J Cell Sci. 2007 Apr 15;120(Pt 8):1358-70
pubmed: 17389682
BMC Neurol. 2007 Jun 09;7:13
pubmed: 17559686
Neuroscientist. 2007 Dec;13(6):572-9
pubmed: 18000068
Conf Proc IEEE Eng Med Biol Soc. 2007;2007:6653-6
pubmed: 18003551
J Neurosci. 2008 Feb 13;28(7):1546-56
pubmed: 18272676
J Neurosci Res. 2008 Aug 15;86(11):2392-402
pubmed: 18431812
Methods Mol Biol. 2007;403:15-36
pubmed: 18827985
Neurotox Res. 2009 Jan;15(1):24-37
pubmed: 19384585
Adv Exp Med Biol. 1990;268:245-53
pubmed: 1981645
Biotechnol Bioeng. 2010 Mar 1;105(4):823-33
pubmed: 19882735
J Alzheimers Dis. 2010;19(1):191-210
pubmed: 20061638
J Mol Neurosci. 2010 Sep;42(1):17-27
pubmed: 20155332
Exp Neurol. 2010 Nov;226(1):173-82
pubmed: 20816824
J Neurosci. 2012 Mar 14;32(11):3910-6
pubmed: 22423111
Biotechnol Prog. 2012 Sep-Oct;28(5):1329-35
pubmed: 22848041
Int J Cell Biol. 2012;2012:683897
pubmed: 22991514
PLoS One. 2012;7(11):e48354
pubmed: 23189129
Neurochem Int. 2013 Mar;62(4):418-24
pubmed: 23411410
Sci Transl Med. 2013 Mar 20;5(177):177ps5
pubmed: 23515075
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:1-12
pubmed: 23800465
Exp Biol Med (Maywood). 2013 Aug 1;238(8):923-31
pubmed: 23970408
J Neural Transm (Vienna). 2014 Aug;121(8):819-36
pubmed: 24562403
PLoS One. 2014 Mar 03;9(3):e90041
pubmed: 24595264
Life Sci. 2014 Apr 25;102(1):16-27
pubmed: 24603130
J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):247-253
pubmed: 24710940
Brain Stimul. 2014 Sep-Oct;7(5):643-9
pubmed: 24924734
Environ Res. 2014 Oct;134:74-80
pubmed: 25046815
Appl Biochem Biotechnol. 2014 Oct;174(4):1233-1245
pubmed: 25099373
ACS Nano. 2014 Oct 28;8(10):10125-38
pubmed: 25248035
Cell Prolif. 2014 Dec;47(6):485-93
pubmed: 25319486
Nat Med. 2015 Jan;21(1):92-98
pubmed: 25501906
Biomaterials. 2015 Jun;53:76-85
pubmed: 25890708
PLoS One. 2015 May 15;10(5):e0126963
pubmed: 25978363
Stem Cell Res Ther. 2015 Jul 24;6:133
pubmed: 26204925
Ann Phys Rehabil Med. 2015 Sep;58(4):208-213
pubmed: 26319963
Nat Mater. 2016 Feb;15(2):217-26
pubmed: 26569474
Nat Biotechnol. 2016 Jan;34(1):43-4
pubmed: 26744980
Sci Rep. 2016 Feb 18;6:21774
pubmed: 26887777
Neurotoxicology. 2016 Mar;53:290-300
pubmed: 26945731
Nat Neurosci. 2016 May;19(5):756-761
pubmed: 26950006
PLoS One. 2016 Mar 07;11(3):e0150923
pubmed: 26950212
Stem Cell Res Ther. 2016 Apr 18;7(1):54
pubmed: 27086866
Sci Rep. 2016 Jun 15;6:27791
pubmed: 27301770
Elife. 2016 Sep 08;5:
pubmed: 27606500
J Neural Eng. 2017 Jun;14(3):031001
pubmed: 28198703
Nat Rev Neurosci. 2017 Mar 17;18(4):236-249
pubmed: 28303017
EMBO J. 2017 Jun 14;36(12):1643-1646
pubmed: 28536151
Front Mol Neurosci. 2017 Jun 28;10:199
pubmed: 28701917
FEBS Lett. 1987 Oct 19;223(1):143-7
pubmed: 2889618
Stem Cells Int. 2017;2017:9898439
pubmed: 28932245
Mol Neurobiol. 2018 Jul;55(7):5698-5714
pubmed: 29039021
ChemMedChem. 2018 Mar 6;13(5):446-452
pubmed: 29377520
Nature. 2018 Apr;556(7702):515-519
pubmed: 29670280
Glob Adv Health Med. 2018 May 18;7:2164956118777472
pubmed: 29796339
Basic Clin Neurosci. 2018 May-Jun;9(3):167-176
pubmed: 30034647
Front Neural Circuits. 2018 Nov 12;12:97
pubmed: 30483065
FEBS Lett. 1994 Jul 25;349(1):1-6
pubmed: 8045284
Fundam Appl Toxicol. 1997 Jan;35(1):55-63
pubmed: 9024673
Cell Tissue Res. 1998 Feb;291(2):217-30
pubmed: 9426309
FASEB J. 1999 Jan;13(1):95-102
pubmed: 9872934